Leukemia
Researchers from the United States and Italy detail new studies and findings in the area of leukemia
Published in Medical Letter on the CDC and FDA, May 24th, 2006
Study 1: The risk of acute myeloid leukemia (AML) associated with treatments for Hodgkin lymphoma was assessed.
"Treatments for Hodgkin lymphoma are associated with large relative risks of AML, but there are few estimates of the excess absolute risk (EAR), a useful measure of disease burden. One-year Hodgkin lymphoma survivors (N=35,511) were identified within 14 population-based cancer registries in Nordic countries and North America from January 1, 1970, through December 31, 2001," researchers in the United States reported.
"We used Poisson...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Environmental Health
Lead exposure increases risk of low birth weight in Idaho - HIV/AIDS Epidemiology
Current trends in Rwanda's HIV/AIDS epidemic reviewed - Legionellosis
Monochloramine may reduce Legionella colonization of water systems - Pediatric Vaccine
DTaP and MMR shortages impact timeliness of child vaccination coverage - Pneumococcal Vaccine
Pneumococcal vaccine reduces rate of drug-resistant Streptococcus pneumoniae infections - Adenoviral Vector
Replication properties of human adenovirus in different animal species described - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
